
Novo's Martin Holst Lange Talks New Weight Loss Shot
Bloomberg Talks
00:00
Plans to Improve CagriSema
Martin outlines ongoing Redefine 11 and planned phase three higher-dose studies to optimize titration and efficacy.
Play episode from 03:45
Transcript


